Series D - Recursion Pharmaceuticals - Sep 9, 2020 Funding Round Profile - Cointime

Bitcoin $97,555.69 +0.78%
Ethereum $3,290.32 -1.46%
BNB $619.20 -0.85%
Optimism $2.18 +3.43%
Arbitrum $0.79 -0.61%
Solana $253.42 +0.61%
Polygon $0.45 +0.01%
Cosmos $7.02 +10.27%
Avalanche $38.20 +7.94%

Bitcoin $97,555.69 +0.78%
Ethereum $3,290.32 -1.46%
BNB $619.20 -0.85%
Optimism $2.18 +3.43%
Arbitrum $0.79 -0.61%
Solana $253.42 +0.61%
Polygon $0.45 +0.01%
Cosmos $7.02 +10.27%
Avalanche $38.20 +7.94%

Recursion Pharmaceuticals

company

Funding Round

Series D

Money Raised

$ 239M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Advantage Capital	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Feb 12, 2018	Series B	0	Advantage Capital	Detail
Oct 4, 2017	Series B	$ 60M	Advantage Capital	Detail
Nov 25, 2015	Series A	0	Advantage Capital	Detail
Feb 25, 2015	Grant	$ 1.50M	National Institutes of Health	Detail